Vestor Capital’s AbbVie ABBV Stock Holding History

Vestor Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.6M	Sell	71,770 -369,951	-84%	-$82.1M	1.13%	27
2025 Q4	$22.9M	Buy	441,721 +428,008	+3,121%	+$97.5M	1.58%	17
2025 Q3	$3.17M	Sell	13,713 -257,385	-95%	-$52.4M	0.2%	73
2025 Q2	$74.7M	Buy	271,098 +257,364	+1,874%	+$47.8M	5.6%	2
2025 Q1	$2.88M	Sell	13,734 -24,349	-64%	-$4.73M	0.24%	68
2024 Q4	$6.77M	Buy	38,083 +24,581	+182%	+$4.52M	0.52%	45
2024 Q3	$2.67M	Buy	13,502 +14	+0.1%	+$2.61K	0.21%	62
2024 Q2	$2.31M	Sell	13,488 -370	-3%	-$61.3K	0.19%	67
2024 Q1	$2.52M	Sell	13,858 -28	-0.2%	-$4.83K	0.21%	78
2023 Q4	$2.15M	Buy	13,886 +425	+3%	+$62K	0.21%	76
2023 Q3	$2.01M	Sell	13,461 -705	-5%	-$103K	0.22%	76
2023 Q2	$1.91M	Sell	14,166 -16,356	-54%	-$2.4M	0.2%	74
2023 Q1	$4.86M	Sell	30,522 -1,157	-4%	-$177K	0.57%	56
2022 Q4	$5.12M	Sell	31,679 -1,012	-3%	-$155K	0.62%	50
2022 Q3	$4.39M	Sell	32,691 -70,968	-68%	-$10.2M	0.58%	49
2022 Q2	$15.9M	Buy	103,659 +40,595	+64%	+$6.2M	1.92%	16
2022 Q1	$10.2M	Buy	63,064 +50,183	+390%	+$7.29M	1.01%	32
2021 Q4	$1.74M	Sell	12,881 -416	-3%	-$49.1K	0.17%	74
2021 Q3	$1.43M	Buy	13,297 +1,064	+9%	+$122K	0.15%	80
2021 Q2	$1.38M	Hold	12,233	–	–	0.14%	76
2021 Q1	$1.32M	Hold	12,233	–	–	0.15%	75
2020 Q4	$1.31M	Buy	12,233 +40	+0.3%	+$3.84K	0.16%	70
2020 Q3	$1.07M	Buy	+12,193	New	+$1.15M	0.15%	67
2020 Q1	$956K	Sell	12,550 -6,341	-34%	-$540K	0.19%	69
2019 Q4	$1.67M	Buy	18,891 +1,449	+8%	+$120K	0.25%	73
2019 Q3	$1.32M	Buy	17,442 +1,335	+8%	+$91.5K	0.22%	67
2019 Q2	$1.17M	Sell	16,107 -175	-1%	-$13.8K	0.21%	65
2019 Q1	$1.31M	Sell	16,282 -1,639	-9%	-$134K	0.24%	65
2018 Q4	$1.65M	Hold	17,921	–	–	0.36%	56
2018 Q3	$1.7M	Hold	17,921	–	–	0.33%	67
2018 Q2	$1.66M	Hold	17,921	–	–	0.34%	68
2018 Q1	$1.7M	Sell	17,921 -201	-1%	-$22.1K	0.35%	68
2017 Q4	$1.75M	Buy	18,122 +9,947	+122%	+$937K	0.38%	64
2017 Q3	$726K	Sell	8,175 -197	-2%	-$15K	0.16%	70
2017 Q2	$607K	Buy	8,372 +197	+2%	+$13.2K	0.15%	71
2017 Q1	$533K	Buy	8,175 +404	+5%	+$25.4K	0.12%	82
2016 Q4	$487K	Sell	7,771 -444	-5%	-$27.1K	0.13%	61
2016 Q3	$518K	Sell	8,215 -205	-2%	-$13.3K	0.14%	61
2016 Q2	$521K	Hold	8,420	–	–	0.15%	60
2016 Q1	$481K	Buy	8,420 +1,861	+28%	+$104K	0.14%	60
2015 Q4	$389K	Buy	6,559 +88	+1%	+$5.07K	0.11%	62
2015 Q3	$352K	Buy	6,471 +613	+10%	+$39.9K	0.11%	62
2015 Q2	$394K	Sell	5,858 -50	-0.8%	-$3.26K	0.12%	58
2015 Q1	$346K	Buy	5,908 +4,517	+325%	+$273K	0.12%	53
2014 Q4	$91K	Hold	1,391	–	–	0.03%	83
2014 Q3	$80K	Buy	+1,391	New	+$77.2K	0.03%	77

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vestor Capital's ABBV Position: Q1 2026 in Review

Vestor Capital reduced its AbbVie (ABBV) stake by 84% in Q1 2026, selling an estimated $82.1M and leaving 71,770 shares worth $15.6M. The position accounts for 1.13% of the portfolio, ranked #27.

Vestor Capital first reported a position in ABBV in Q3 2014 and has held it in 46 quarters since. The position peaked at $74.7M in Q2 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Vestor Capital held 71,770 shares of AbbVie worth $15.6M as of Q1 2026.
Vestor Capital sold 369,951 AbbVie shares in Q1 2026, an estimated $82.1M.
AbbVie made up 1.13% of Vestor Capital's portfolio in Q1 2026, its #27 holding.
Vestor Capital first reported a position in AbbVie in Q3 2014 and has held it in 46 quarters since.
Vestor Capital's AbbVie position peaked at $74.7M in Q2 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Vestor Capital's 13F filing for Q1 2026, filed 21 May 2026.